GlobeNewswire Inc.··ActgTecovirimat Shows No Clinical Benefit Over Placebo in Mpox Trial
Tecovirimat showed no clinical benefit over placebo in treating mpox, with 79% vs 81% achieving resolution by day 29 in a major trial.
SIGAclinical trialtecovirimat